Progress in the development of ultra-long-acting local anesthetics

Regional Anesthesia

Volumn 22, Issue 6, 1997, Pages 543-551

  Kuzma, Paul J ^a   Kline, Mark D ^a   Calkins, Mark D ^a   Staats, Peter S ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Liposomes; Local anesthetics; Polymers

Indexed keywords

ALIPHATIC AMINE; ARACHIS OIL; BUPIVACAINE; BUTYLCAINE; DEXAMETHASONE; DEXTRAN; ETIDOCAINE; HYALURONIC ACID; IOFENDYLATE; LIDOCAINE; LIPOSOME; LOCAL ANESTHETIC AGENT; METHOXYFLURANE; PHOSPHATIDYLCHOLINE; POLYMER; PRILOCAINE; PROCAINE; SAXITOXIN; TETRACAINE; TETRODOTOXIN; TETRYLAMMONIUM;

ARTICLE; CRYSTAL; DRUG FORMULATION; DRUG MIXTURE; DRUG STRUCTURE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LOCAL ANESTHESIA; MICROENCAPSULATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANESTHETICS, LOCAL; ANIMALS; DELAYED-ACTION PREPARATIONS; HUMANS; TIME FACTORS; VEHICLES;

EID: 0031441595     PISSN: 0146521X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Koller C. On the use of cocaine for producing anaesthesia of the eye. Lancet 1884: ii: 990-992.
2. Hall RJ. Hydrochlorate of cocaine. NY Med J 1884: 40: 643-644.
3. Corning JL. Spinal anesthesia and local medication of the cord. NY Med J 1885: 42: 483-485.
4. Einhorn A. On the chemistry of local anesthetics. MWM 1889: 46: 1218-1220.
5. Covino BG. Ultralong-acting local anesthetic agents. Anesthesiology 1981: 54: 263-264.
6. Ross SB, Åkerman BA. Cyclization of three N-W-Haloalkyl-N-Methylaminoaceto-2,6-Xylidide derivatives in relation to their local anesthetic effect in vitro and in vivo. J Pharmacol Exp Ther 1972: 182: 351-361.
7. Adams HJ, Blair MR, Takman BH. The local anesthetic activity of tetradotoxin alone and in combination with vasoconstrictors and local anesthetics. Anesth Analg 1976: 55: 568-573.
8. Ogura Y, Mori Y. Mechanism of local anesthetic action of crystalline tetrodotoxin and its derivatives. Eur J Pharmacol 1968: 3: 58-67.
9. Evans MH. Topical application of saxitoxin and tetrododtoxin to peripheral nerves and spinal roots in cat. Toxicon 1968: 5: 289-294.
10. Scurlock JE, Curtis BM. Tetraethylammonium derivatives: Ultralong-acting local anesthetics? Anesthesiology 1981: 54: 265-269.
11. Scurlock JE, Curtis BM. The mechanism of action of local anesthesia by tetraethylammonium derivatives. Anesthesiology 1981: 54: 270-277.
12. Lipfert P, Seitz RJ, Arndt JO. Ultralong-lasting nerve block: Triethyldodecyl ammonium bromide is probably a neurotoxin rather than a local anesthetic. Anesthesiology 1987: 67: 896-904.
13. Davison AN. Metabolically inert proteins of the central nervous system, muscle and tendon. Biochem J 1961: 78: 272-280.
14. Rodriguez De Lores Arnaiz G, Alberici De Canal M, De Robertis E. Turnover of proteins in subcellular fractions of rat cerebral cortex. Brain Res 1971: 31: 179-184.
15. Korsten HH, Grouls RJ. Long-lasting sensory blockade by an epidurally injected material-based drug delivery system. American Pain Society Bulletin 1996: 6: 1-4.
16. Korsten HH, Ackerman EW, Grouls RJ, van Zundert AA, Boon WF, Bal F, Crommelin MA, Ribot JG, Hoefsloot F, Sloof JL. Long-lasting epidural sensory blockade by n-butyl-p-aminobenzoate in the terminally ill intractable cancer pain patient. Anesthesiology 1991: 75: 950-960.
17. Shulman M. Treatment of cancer pain with epidural butyl-aminobenzoate suspension. Reg Anesth 1987: 12: 1-4.
18. Longer MA, Robinson JR. Sustained-release drug delivery systems. In: Gennaro AR, ed. Remington's Pharmaceutical Sciences, 18th ed. Easton, PA, Mack Publishing, 1990: 1676-1693.
19. Hassan HG, Renck H, Lindberg B, Åkerman B, Hellquist R. Effects of adjuvants to local anaesthetics on their duration I. Acta Anesthesiol Scand 1985: 29: 375-379.
20. Hassan HG, Renck H, Lindberg B, Åckerman B. Effects of adjuvants to local anaesthetics on their duration II. Acta Anesthesiol Scand 1985: 29: 380-383.
21. Hassan HG, Åkerman B, Renck H, Lindberg B, Lindquist B. Effects of adjuvants to local anaesthetics on their duration III. Acta Anesthesiol Scand 1985: 29: 384-388.
22. Scurlock JE, Curtis BM. Dextran-local anesthetic interactions. Anesth Analg 1980: 59: 335-340.
23. Richter AW, Ryde EM, Zetterstrom EO. Non-immunogenicity of a purified sodium hyaluronate preparation in man. Arch Allergy Appl Immunol 1979: 59: 45-48.
24. Langerman L, Golomb E, Benita S. Spinal anesthesia: Significant prolongation of the pharmacologic effect of tetracaine with lipid solution of the agent. Anesthesiology 1991: 74: 105-107.
25. Langerman L, Grant GJ, Zakowski M, Golomb E, Ramanathan S, Turndorf H. Prolongation of spinal anesthesia: Differential action of a lipid carrier on tetracaine, lidocaine, and procaine. Anesthesiology 1992: 77: 475-481.
26. Langerman L, Grant GJ, Zakowski M, Golomb E, Ramanathan S, Turndorf H. Prolongation of epidural anesthesia using a lipid drug carrier with procaine, lidocaine, and tetracaine. Anesth Analg 1992: 75: 900-905.
27. Legros F, Luo H, Bourgeois P, Lafont N, Boogarts J. Influence of different liposomal formulations on pharmacokinetics of encapsulated bupivicaine. Anesthesiology 1990: 73: A851.
28. Djordjevich L, Ivankovich AD, Chigurupati R, Woronowicz A, McCarthy R. Efficacy of liposome-encapsulated bupivicaine. Anesthesiology 1986: 65: A185.
29. Mashimo T, Uchida I, Pak M, Shibata A, Nishimura S, Ingaki Y, Yoshiya I. Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine. Anesth Analg 1992: 74: 827-834.
30. Yanez AM, Wallace M, Ho R, Shen D, Yaksh XL. Touch-evoked agitation produced by spinally administered phospholipid emulsion and liposomes in rats. Anesthesiology 1995: 82: 1189-1198.
31. Haynes DH. Phospholipid-coated microcrystals: Injectable formulations of water-insoluble drugs. United States Patent 5091187, 1992.
32. Boedeker BH, Lojeski EW, Kline MD, Haynes DH. Ultra-long-duration local anesthetia produced by injection of Lecithin-coated tetracaine microcrystals. J Clin Pharmac 1994: 34: 699-702.
33. Kline MD, Boedeker BH, Mattix ME. Intradermal toxicity of lecithin-coated microcrystalline tetracaine. Anesthesiology 1992: 77: A800.
34. Kuzma PJ, Kline MD, Boedeker BH, Haynes DH. Microcrystalline bupivacaine coated with lecithin produces ultra-long duration local anesthesia in the rat tail. Anesthesiology 1994: 81: A1033.
35. Kuzma PJ, Kline MD, Boedeker BH, Young PC, Mattix ME, Haynes DH. Tissue toxicity of lecithin-coated bupivacaine microcrystals after intradermal infiltration. Anesthesiology 1994: 81: A1034.
36. Kirkpatrick AF, Lavallee-Grey M, Haynes DH. Long duration local anesthesia with lecithin-coated microdroplets of methoxyflurane: Studies with rat skin. Reg Anesth 1991: 16: 164-172.
37. Haynes DH, Kirkpatrick AF. Long duration local anesthesia with lecithin-coated microdroplets of methoxyflurane: Studies with human skin. Reg Anesth 1991: 16: 173-180.
38. Masters DB, Berde CB, Dutta SK, Griggs CT, Hu D, Kupsky W, Langer R. Prolonged regional nerve blockade by controlled release of local anesthetic from a biodegradable polymer matrix. Anesthesiology 1996: 79: 340-346.